Development and Evaluation of Novel PET Tracers for Imaging Cannabinoid Receptor Type 2 in Brain

By Slavik Roger   Bieri Daniel   Čermak Stjepko   Müller Adrienne   Krämer Stefanie D.   Weber Markus   Schibli Roger   Ametamey Simon M.   Mu Linjing  

CHIMIA International Journal for Chemistry, Vol. 68, Iss. 4, 2014-04 ,pp. : 208-210

Swiss Chemical Society

Access to resources Recommend Favorite

Design, Synthesis, and Evaluation of an 18F‐Labeled Radiotracer Based on Celecoxib–NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase‐2 (COX‐2)

By  

CHEMMEDCHEM, Vol. 1860-7179, Iss. 10, 2015-10 ,pp. : 1635-1640

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design, Synthesis, and Evaluation of an 18F‐Labeled Radiotracer Based on Celecoxib–NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase‐2 (COX‐2)

By  

CHEMMEDCHEM, Vol. 10, Iss. 10, 2015-10 ,pp. : 1635-1640

John Wiley & Sons Inc

Access to resources Recommend Favorite

MEDITOMO: a high performance software package for 3D SPECT imaging

By Murli A.  

International Journal of Computer Mathematics, Vol. 86, Iss. 1, 2009-01 ,pp. : 31-56

Taylor & Francis Ltd

Access to resources Recommend Favorite

Synthesis and bioevaluation of 4‐chloro‐2‐tert‐butyl‐5‐[2‐[[1‐[2‐[18F]fluroethyl]‐1H‐1,2,3‐triazol‐4‐yl]methyl]phenylmethoxy]‐3(2H)‐pyridazinone as potential myocardial perfusion imaging agent with PET

By  

JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS (ELECTRONIC), Vol. 58, Iss. 8, 2015-06 ,pp. : 349-354

John Wiley & Sons Inc

Access to resources Recommend Favorite